Grifols GRFS
NASDAQ GRFS
$8.00 +0.01 (+0.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Grifols (GRFS) Change in Cash (2009 - 2020)

Grifols' (GRFS) quarterly Change in Cash came in at -$5.9 million in Q4 2016, up 95.67% YoY from -$3.0 million in Q1 2016, and up 99.09% on a QoQ basis from -$644.6 million in Q3 2016.

Grifols (GRFS) Change in Cash (2009 - 2020) Analysis & Trends

Grifols (GRFS) has 8 years of Change in Cash data on file, last reported at -$5.9 million in Q4 2016.

  • Quarterly Change in Cash rose 95.67% year-over-year to -$5.9 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was -$901.1 million (down 1520.11% YoY) and the FY2025 annual result came in at -$180.4 million, down 137.44% from the prior year.
  • Change in Cash climbed to -$5.9 million in Q4 2016, from -$644.6 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $631.9 million in Q2 2015 to a low of -$644.6 million in Q3 2016.
  • A 5-year average of -$4.5 million and a median of -$2.8 million in 2012 frame the typical range for Change in Cash.
  • Annual changes were most pronounced in 2013 — Change in Cash soared 39081.59% — and 2015, when it plunged 1059.4%.
  • Tracing GRFS's Change in Cash over 5 years: stood at $94.3 million in 2012, then jumped by 218.2% to $300.1 million in 2013, then sank by 186.85% to -$260.7 million in 2014, then surged by 47.88% to -$135.9 million in 2015, then surged by 95.67% to -$5.9 million in 2016.
  • The last three Change in Cash figures came in at -$5.9 million (Q4 2016), -$644.6 million (Q3 2016), and -$135.9 million (Q4 2015), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn -1.27 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn -2.82 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn 1.49 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn 739.00 Mn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn -
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn 1.95 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn -4.45 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn -727.00 Mn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn -
10 Grifols 5.45 Bn 4.45 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2020 -8.76 Mn
Dec 31, 2019 -59.70 Mn
Mar 31, 2019 -478.88 Mn
Dec 31, 2018 287.63 Mn
Jun 30, 2018 -265.87 Mn
Mar 31, 2018 5.84 Mn
Dec 31, 2017 1.84 Bn
Jun 30, 2017 -1.72 Bn
Mar 31, 2017 1.83 Bn
Dec 31, 2016 -5.89 Mn
Sep 30, 2016 -644.62 Mn
Dec 31, 2015 -135.86 Mn
Sep 30, 2015 -114.69 Mn
Jun 30, 2015 631.90 Mn
Mar 31, 2015 -317.90 Mn
Dec 31, 2014 -260.66 Mn
Sep 30, 2014 277.27 Mn
Jun 30, 2014 -33.13 Mn
Mar 31, 2014 33.14 Mn
Dec 31, 2013 300.12 Mn